Breast

Oncology·MeSH: Breast Neoplasms

510 drugs in development·130 companies·3 clinical trials

Drug Pipeline by Phase

Approved(29)

Drug	Company
ABRAXANE	ImmunityBio, Inc. (IBRX)
afinitor	Novartis AG (NVS)
Aware Breast Self-Exam product	BIOMERICA INC (BMRA)
Aybintio (SB8)	Organon & Co. (OGN)
BRACAnalysis CDx	MYRIAD GENETICS INC (MYGN)
cerianna	GE HealthCare Technologies Inc. (GEHC)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
eribulin	DR REDDYS LABORATORIES LTD (RDY)
everolimus	Mylan II B.V. (MYL)
ibrance	PFIZER INC (PFE)
Inluriyo	ELI LILLY & Co (LLY)
kisqali femara co-pack	Novartis AG (NVS)
Lynparza	Merck & Co., Inc. (MRK)
MARGENZA	MACROGENICS INC (MGNX)
menacalc	METASTAT, INC. (MTST)
metasite breast	METASTAT, INC. (MTST)
metsera's monthly met-097i+met-233i combination	PFIZER INC (PFE)
nerlynx	PUMA BIOTECHNOLOGY, INC. (PBYI)
ogivri	Mylan II B.V. (MYL)
Ontruzant (SB3)	Organon & Co. (OGN)
paclitaxel	Mylan II B.V. (MYL)
theralink assay for breast cancer	THERALINK TECHNOLOGIES, INC. (THER)
trodelvy	Immunome Inc. (IMNM)
Trodelvy	Royalty Pharma plc (RPRX)
tukysa	Seagen Inc. (SGEN)
tykerb	Novartis AG (NVS)
Verzenio®	ELI LILLY & Co (LLY)

Phase 3(156)

Drug	Company
18F-FAPI-74	ENANTA PHARMACEUTICALS INC (ENTA)
Abraxane	Merus N.V. (MRUS)
ac regimen	GH Research PLC (GHRS)
adjuvant chemotherapy + ovarian function suppression	CG Oncology, Inc. (CGON)
Administration of ceralasertib	ASTRAZENECA PLC (AZN)
Administration of ceralasertib in combination with AZD5305	ASTRAZENECA PLC (AZN)
Administration of ceralasertib monotherapy	ASTRAZENECA PLC (AZN)
Alpelisib	Relay Therapeutics, Inc. (RLAY)
ansastrozole	Novartis AG (NVS)
arimidex	ASTRAZENECA PLC (AZN)
arimidex dummy	ASTRAZENECA PLC (AZN)
Aromatase inhibitor	Merus N.V. (MRUS)
arx788	Ambrx Biopharma Cayman, Inc. (AMAM)
Atirmociclib	ASTRAZENECA PLC (AZN)
Atirmociclib	Olema Pharmaceuticals, Inc. (OLMA)
AZD2014	ASTRAZENECA PLC (AZN)
AZD8205	ASTRAZENECA PLC (AZN)
AZD8205 and AZD5305	ASTRAZENECA PLC (AZN)
AZD8205 and AZD5305 and AZD2936	ASTRAZENECA PLC (AZN)
azd8205 in combination with azd9574 plus rilvegostomig	ASTRAZENECA PLC (AZN)
azd9833	ASTRAZENECA PLC (AZN)
bg-75202	BeOne Medicines Ltd. (ONC)
BG-75202	BeOne Medicines Ltd. (ONC)
bgb-21447	BeOne Medicines Ltd. (ONC)
bgb-43395	BeOne Medicines Ltd. (ONC)
bgb-43395	BeOne Medicines Ltd. (ONC)
BGB-43395	BeOne Medicines Ltd. (ONC)
bl-m07d1	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
bl-m07d1	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Blood and saliva samples	Merus N.V. (MRUS)
Bria-IMT™	BriaCell Therapeutics Corp. (BCTX)
Bupivacaine Injection [Marcaine]	COGNITION THERAPEUTICS INC (CGTX)
byl719	NOVARTIS AG (NVSEF)
Camizestrant	ASTRAZENECA PLC (AZN)
Capivasertib	ASTRAZENECA PLC (AZN)
cemiplimab	GH Research PLC (GHRS)
chemotherapy	GH Research PLC (GHRS)
chemotherapy	GH Research PLC (GHRS)
combination product	PFIZER INC (PFE)
cyclin-dependent kinase 4 inhibitor	GH Research PLC (GHRS)
cyclin-dependent kinase 6 inhibitor	GH Research PLC (GHRS)
Dabrafenib plus Trametinib	ASTRAZENECA PLC (AZN)
Dato-DXd	ASTRAZENECA PLC (AZN)
Datopotamab Deruxtecan	Merus N.V. (MRUS)
dc1 vaccine	GH Research PLC (GHRS)
elacestrant	Rani Therapeutics Holdings, Inc. (RANI)
elacestrant	Radius Health, Inc. (RDUS)
epirubicin	ASTRAZENECA PLC (AZN)
Epirubicin	Merck & Co., Inc. (MRK)
Epirubicin	Merus N.V. (MRUS)
Epirubicin Hydrochloride	Merck & Co., Inc. (MRK)
Eribulin	Jazz Pharmaceuticals plc (JAZZ)
Eribulin	Merus N.V. (MRUS)
Eribulin mesylate	ASTRAZENECA PLC (AZN)
Eribulin Mesylate	Merus N.V. (MRUS)
erlotinib	ASTRAZENECA PLC (AZN)
faslodex dummy	ASTRAZENECA PLC (AZN)
Gardasill 9™ vaccine	UNITED THERAPEUTICS Corp (UTHR)
Gedatolisib	Relay Therapeutics, Inc. (RLAY)
Giredestrant	ENANTA PHARMACEUTICALS INC (ENTA)
glsi-100	Greenwich LifeSciences, Inc. (GLSI)
GnRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
goserelin	Novartis AG (NVS)
goserelin	Sanofi (SNY)
Goserelin	Novartis AG (NVS)
Goserelin	Myovant Sciences Ltd. (MYOV)
Goserelin Acetate	Myovant Sciences Ltd. (MYOV)
her2-targeted therapy	GH Research PLC (GHRS)
hormone therapy	GH Research PLC (GHRS)
Hormone Therapy	Filana Therapeutics Inc. (FLNA)
Imlunestrant + Goserelin	ELI LILLY & Co (LLY)
Inavolisib	ENANTA PHARMACEUTICALS INC (ENTA)
infigratinib	BridgeBio Pharma, Inc. (BBIO)
Infigratinib (low-dose)	BridgeBio Pharma, Inc. (BBIO)
interferon infiltration of the inoculation site	BriaCell Therapeutics Corp. (BCTX)
interferon inoculation	BriaCell Therapeutics Corp. (BCTX)
Investigator's selection of appropriate chemotherapy regimen	Filana Therapeutics Inc. (FLNA)
Ipatasertib	ENANTA PHARMACEUTICALS INC (ENTA)
JAK Inhibitor	ENANTA PHARMACEUTICALS INC (ENTA)
lasofoxifene	LeonaBio, Inc. (LONA)
leuprolide	Novartis AG (NVS)
Leuprolide	Novartis AG (NVS)
LHRH Agonist	Myovant Sciences Ltd. (MYOV)
LHRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
low-dose infigratinib	BridgeBio Pharma, Inc. (BBIO)
luteinizing hormone-releasing hormone agonist	ASTRAZENECA PLC (AZN)
LY4064809	ELI LILLY & Co (LLY)
LY4064809	Merus N.V. (MRUS)
margetuximab	MACROGENICS INC (MGNX)
neoadjuvant chemotherapy	GH Research PLC (GHRS)
Neoadjuvant Chemotherapy	Merus N.V. (MRUS)
Neoadjuvant olaparib	Filana Therapeutics Inc. (FLNA)
Neratinib	ENANTA PHARMACEUTICALS INC (ENTA)
New Formulation of Niraparib and Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
Olaparib	Merck & Co., Inc. (MRK)
OP-1250	Olema Pharmaceuticals, Inc. (OLMA)
ovarian function suppression + aromatase inhibitor	CG Oncology, Inc. (CGON)
Palazestrant	Olema Pharmaceuticals, Inc. (OLMA)
palazestrant (formerly known as OP-1250)	Olema Pharmaceuticals, Inc. (OLMA)
palazestrant (OP-1250)	Olema Pharmaceuticals, Inc. (OLMA)
Patritumab deruxtecan	Merck & Co., Inc. (MRK)
pegfilgrastim	GH Research PLC (GHRS)
pertuzumab	GH Research PLC (GHRS)
pertuzumab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
pertuzumab	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
pertuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
pertuzumab	NOVARTIS AG (NVSEF)
pertuzumab	Crinetics Pharmaceuticals, Inc. (CRNX)
pertuzumab	PFIZER INC (PFE)
pertuzumab	Novartis AG (NVS)
Pertuzumab	Jazz Pharmaceuticals plc (JAZZ)
Pertuzumab	ASTRAZENECA PLC (AZN)
Pertuzumab	Merck & Co., Inc. (MRK)
Pertuzumab	Filana Therapeutics Inc. (FLNA)
Pertuzumab	MACROGENICS INC (MGNX)
Pertuzumab	Merus N.V. (MRUS)
Pertuzumab IV	Filana Therapeutics Inc. (FLNA)
Pertuzumab IV	Merus N.V. (MRUS)
Pertuzumab IV	ENANTA PHARMACEUTICALS INC (ENTA)
PF-07220060 CDK4 inhibitor	Merus N.V. (MRUS)
PHESGO	Merus N.V. (MRUS)
Physician's choice chemotherapy	ASTRAZENECA PLC (AZN)
Physician's choice of chemotherapy.	MACROGENICS INC (MGNX)
Physician's Choice of Endocrine Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
retifanlimab	BriaCell Therapeutics Corp. (BCTX)
sacituzumab govitecan	Phoenix Life Sciences International Limited. (PLSI)
sacituzumab govitecan	Phoenix Life Sciences International Limited. (PLSI)
sacituzumab govitecan	IMMUNOMEDICS INC (IMMU)
sacituzumab govitecan	GILEAD SCIENCES, INC. (GILD)
Sacituzumab tirumotecan	Merck & Co., Inc. (MRK)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
Sapacitabine	ASTRAZENECA PLC (AZN)
sar439859	Sanofi (SNY)
SGLT-2 inhibitor	ENANTA PHARMACEUTICALS INC (ENTA)
standard adjuvant endocrine therapy	ELI LILLY & Co (LLY)
standard neoadjuvant chemotherapy regimens	Filana Therapeutics Inc. (FLNA)
sv-br-1-gm	BriaCell Therapeutics Corp. (BCTX)
SYS6010	Merus N.V. (MRUS)
t-dm1	PFIZER INC (PFE)
T-DM1	BioNTech SE (BNTX)
T-DM1	Merus N.V. (MRUS)
taxane	GH Research PLC (GHRS)
Taxane	ASTRAZENECA PLC (AZN)
taxane compound	GH Research PLC (GHRS)
tesetaxel	Odonate Therapeutics, Inc. (ODT)
Toripalimab Injection	ENANTA PHARMACEUTICALS INC (ENTA)
treatment of physician's choice	BriaCell Therapeutics Corp. (BCTX)
triptorelin	Merus N.V. (MRUS)
Tucatinib	PFIZER INC (PFE)
Tucatinib	ENANTA PHARMACEUTICALS INC (ENTA)
Veliparib	AbbVie Inc. (ABBV)
vepdegestrant	ARVINAS, INC. (ARVN)
Vepdegestrant	PFIZER INC (PFE)
Vinorelbine	Jazz Pharmaceuticals plc (JAZZ)
Vinorelbine Tartrate	Merus N.V. (MRUS)
Zanidatamab	Jazz Pharmaceuticals plc (JAZZ)

Phase 2(140)

Drug	Company
-endoxifen	ATOSSA THERAPEUTICS, INC. (ATOS)
18F-FDG	ENANTA PHARMACEUTICALS INC (ENTA)
350 mg leronlimab	CytoDyn Inc. (CYDY)
525 mg leronlimab	CytoDyn Inc. (CYDY)
700 mg leronlimab	CytoDyn Inc. (CYDY)
Abiraterone Acetate	Myovant Sciences Ltd. (MYOV)
abv-1501	ABVC BIOPHARMA, INC. (ABVC)
ad-rts-hil-12	Alaunos Therapeutics, Inc. (TCRT)
ae37	GENEREX BIOTECHNOLOGY CORP (GNBT)
Alpelisib	UNITED THERAPEUTICS Corp (UTHR)
Alpelisib	Crinetics Pharmaceuticals, Inc. (CRNX)
amcenestrant	Sanofi (SNYNF)
amcenestrant	Sanofi (SNY)
Anthracycline	Filana Therapeutics Inc. (FLNA)
Anti-CD40 Agonist Monoclonal Antibody CDX-1140	UNITED THERAPEUTICS Corp (UTHR)
Anti-HER2/HER3 Dendritic Cell Vaccine	UNITED THERAPEUTICS Corp (UTHR)
Anti-PD-1 monoclonal antibody	UNITED THERAPEUTICS Corp (UTHR)
Antiandrogen	Merus N.V. (MRUS)
Antiandrogen	Royalty Pharma plc (RPRX)
Antiandrogen	Janux Therapeutics, Inc. (JANX)
ARV-471	ARVINAS, INC. (ARVN)
azd6244	ASTRAZENECA PLC (AZN)
AZD6738	UNITED THERAPEUTICS Corp (UTHR)
AZD8421	ASTRAZENECA PLC (AZN)
blood samples	Merus N.V. (MRUS)
Blood samples analysis	Merus N.V. (MRUS)
BNT327 Dose Level 1	BioNTech SE (BNTX)
BNT327 Equivalent Q3W Dose	BioNTech SE (BNTX)
BNT327 Optimized Dose	BioNTech SE (BNTX)
Boserolimab	Merus N.V. (MRUS)
Boserolimab	Merck & Co., Inc. (MRK)
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine	UNITED THERAPEUTICS Corp (UTHR)
cdk4 inhibitor	BeOne Medicines Ltd. (ONC)
CDK4 Inhibitor	BeOne Medicines Ltd. (ONC)
CDX-301	UNITED THERAPEUTICS Corp (UTHR)
Ceterizine	ASTRAZENECA PLC (AZN)
CFI-400945	ASTRAZENECA PLC (AZN)
dendritic cell vaccine	GH Research PLC (GHRS)
Dendritic Cell Vaccine	UNITED THERAPEUTICS Corp (UTHR)
Direct Oral Anticoagulant	ENANTA PHARMACEUTICALS INC (ENTA)
disitamab vedotin	PFIZER INC (PFE)
EC4-T4	Filana Therapeutics Inc. (FLNA)
Epirubicin	Filana Therapeutics Inc. (FLNA)
eribulin	Cardiff Oncology, Inc. (CRDF)
eribulin	ALX ONCOLOGY HOLDINGS INC (ALXO)
eribulin	CG Oncology, Inc. (CGON)
Eribulin	BioNTech SE (BNTX)
evorpacept	ALX ONCOLOGY HOLDINGS INC (ALXO)
evorpacept	Cardiff Oncology, Inc. (CRDF)
evorpacept	CG Oncology, Inc. (CGON)
Filgrastim	Filana Therapeutics Inc. (FLNA)
GNRH-A Goserelin	ELI LILLY & Co (LLY)
goserelin	ELI LILLY & Co (LLY)
goserelin	ATOSSA THERAPEUTICS, INC. (ATOS)
Goserelin	ENANTA PHARMACEUTICALS INC (ENTA)
High Dose Interleukin-2	Filana Therapeutics Inc. (FLNA)
Ifinatamab Deruxtecan	Merus N.V. (MRUS)
Immune Checkpoint Inhibitor	ENANTA PHARMACEUTICALS INC (ENTA)
iopofosine I 131	Cellectar Biosciences, Inc. (CLRB)
Iparomlimab and Tuvonralimab	Merus N.V. (MRUS)
Iza-bren	Merus N.V. (MRUS)
JAK Inhibitor	Filana Therapeutics Inc. (FLNA)
l-nmma	GH Research PLC (GHRS)
L-NMMA	Cidara Therapeutics, Inc. (CDTX)
L-NMMA	ADMA BIOLOGICS, INC. (ADMA)
L-NMMA	Relay Therapeutics, Inc. (RLAY)
L-NMMA	Novartis AG (NVS)
L-NMMA	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
L-NMMA	ENANTA PHARMACEUTICALS INC (ENTA)
LBL-024 for Injection	ENANTA PHARMACEUTICALS INC (ENTA)
LEE011	Novartis AG (NVS)
lerociclib	EQRx, Inc. (EQRX)
Leronlimab	CytoDyn Inc. (CYDY)
Leuprolide	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
lhrh analogue	GH Research PLC (GHRS)
Long-acting leronlimab	CytoDyn Inc. (CYDY)
Loperamide	ASTRAZENECA PLC (AZN)
magrolimab	Phoenix Life Sciences International Limited. (PLSI)
Maximum Tolerated Dose of leronlimab	CytoDyn Inc. (CYDY)
Nab-placlitaxel	BioNTech SE (BNTX)
Neratinib	Filana Therapeutics Inc. (FLNA)
ngc-cap	Processa Pharmaceuticals, Inc. (PCSA)
ngc-gem	Processa Pharmaceuticals, Inc. (PCSA)
Olaparib	Crinetics Pharmaceuticals, Inc. (CRNX)
Olaparib	Merus N.V. (MRUS)
Oleclumab	ASTRAZENECA PLC (AZN)
ONA-XR	Context Therapeutics Inc. (CNTX)
palifosfamide	Alaunos Therapeutics, Inc. (TCRT)
Patritumab Deruxtecan	Merus N.V. (MRUS)
pcs6422	Processa Pharmaceuticals, Inc. (PCSA)
PD-1 inhibitors	Filana Therapeutics Inc. (FLNA)
Pegfilgrastim	Filana Therapeutics Inc. (FLNA)
Perflutren Lipid Microspheres	Merus N.V. (MRUS)
Perflutren Lipid Microspheres	Lantheus Holdings, Inc. (LNTH)
Personalized Synthetic Long Peptide Vaccine	ADMA BIOLOGICS, INC. (ADMA)
Personalized Synthetic Long Peptide Vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
PI3K-beta Inhibitor GSK2636771	ENANTA PHARMACEUTICALS INC (ENTA)
piktor	Sensei Biotherapeutics, Inc. (SNSE)
Poly ICLC	ENANTA PHARMACEUTICALS INC (ENTA)
Poly ICLC	ADMA BIOLOGICS, INC. (ADMA)
Posaconazole	Filana Therapeutics Inc. (FLNA)
Propranolol	Structure Therapeutics Inc. (GPCR)
Propranolol Hydrochloride	Structure Therapeutics Inc. (GPCR)
pTVG-HP DNA vaccine	UNITED THERAPEUTICS Corp (UTHR)
QL1706	Valneva SE (VALN)
RO7771950	ENANTA PHARMACEUTICALS INC (ENTA)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
sacituzumab govitecan	GH Research PLC (GHRS)
Sacituzumab Govitecan	ADMA BIOLOGICS, INC. (ADMA)
Sacituzumab Govitecan	Crinetics Pharmaceuticals, Inc. (CRNX)
Sacituzumab Govitecan	ENANTA PHARMACEUTICALS INC (ENTA)
sacituzumab govitecan-hziy	GILEAD SCIENCES, INC. (GILD)
Selinexor Oral Tablet [Xpovio]	ENANTA PHARMACEUTICALS INC (ENTA)
Sintilimab	Merus N.V. (MRUS)
Smallpox and Mpox Vaccine	UNITED THERAPEUTICS Corp (UTHR)
standard neoadjuvant chemotherapy regimens	Clearside Biomedical, Inc. (CLSDQ)
t-cell therapy	GH Research PLC (GHRS)
Temsirolimus	ASTRAZENECA PLC (AZN)
Tocilizumab	Merus N.V. (MRUS)
Toripalimab	Clearside Biomedical, Inc. (CLSDQ)
Tremelimumab	ADMA BIOLOGICS, INC. (ADMA)
Tremelimumab	Crinetics Pharmaceuticals, Inc. (CRNX)
Tremelimumab	ENANTA PHARMACEUTICALS INC (ENTA)
Tumor samples analysis	Merus N.V. (MRUS)
tusamitamab ravtansine	Sanofi (SNY)
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
veledimex	Alaunos Therapeutics, Inc. (TCRT)
vinorelbine	ALX ONCOLOGY HOLDINGS INC (ALXO)
vinorelbine	CG Oncology, Inc. (CGON)
vinorelbine	Cardiff Oncology, Inc. (CRDF)
wokvac vaccine	GH Research PLC (GHRS)
WOKVAC Vaccine	UNITED THERAPEUTICS Corp (UTHR)
z-endoxifen	ATOSSA THERAPEUTICS, INC. (ATOS)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)
Zotatifin	Novartis AG (NVS)
Zotatifin	ADMA BIOLOGICS, INC. (ADMA)
Zotatifin	UNITED THERAPEUTICS Corp (UTHR)
Zotatifin	Crinetics Pharmaceuticals, Inc. (CRNX)
Zotatifin	Relay Therapeutics, Inc. (RLAY)

Phase 1(87)

Drug	Company
[68ga]ga-dwj155	Novartis AG (NVS)
AB248	Filana Therapeutics Inc. (FLNA)
Alpelisib	Olema Pharmaceuticals, Inc. (OLMA)
alpha-lactalbumin breast cancer vaccine	Anixa Biosciences Inc (ANIX)
AP1903	UNITED THERAPEUTICS Corp (UTHR)
aromatase inhibitor	BeOne Medicines Ltd. (ONC)
Aromatase Inhibitor	BeOne Medicines Ltd. (ONC)
ART26.12	ARTELO BIOSCIENCES, INC. (ARTL)
ARV-471	PFIZER INC (PFE)
Atirmociclib	Merus N.V. (MRUS)
avasopasem	Galera Therapeutics, Inc. (GRTX)
axn-27m/imm27m	Instil Bio, Inc. (TIL)
BA3182 (CAB-EpCAM x CAB-CD3)	BioAtla, Inc. (BCAB)
BBI-355	Boundless Bio, Inc. (BOLD)
BBI-825	Boundless Bio, Inc. (BOLD)
BBI-940	Boundless Bio, Inc. (BOLD)
bdc-3042	Bolt Biotherapeutics, Inc. (BOLT)
Berzosertib	Merus N.V. (MRUS)
BET Bromodomain Inhibitor ZEN-3694	ENANTA PHARMACEUTICALS INC (ENTA)
Breast cancer vaccine (alpha-lactalbumin)	Anixa Biosciences Inc (ANIX)
Breast cancer vaccine (α-lactalbumin)	Anixa Biosciences Inc (ANIX)
CAN-3110	Candel Therapeutics, Inc. (CADL)
cemiplimab	Bolt Biotherapeutics, Inc. (BOLT)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
CLR 121125	Cellectar Biosciences, Inc. (CLRB)
CLR 121225	Cellectar Biosciences, Inc. (CLRB)
clr 125	Cellectar Biosciences, Inc. (CLRB)
CT-202	Context Therapeutics Inc. (CNTX)
Denosumab	Aclaris Therapeutics, Inc. (ACRS)
elacestrant	STEMLINE THERAPEUTICS INC (STML)
elvn-002	Enliven Therapeutics, Inc. (ELVN)
emi-le	Mersana Therapeutics, Inc. (MRSN)
Empagliflozin	Merus N.V. (MRUS)
Epidiferphane	Merus N.V. (MRUS)
eribulin	Enliven Therapeutics, Inc. (ELVN)
erlotinib	Boundless Bio, Inc. (BOLD)
estrogen receptor antagonist	BeOne Medicines Ltd. (ONC)
Estrogen Receptor Antagonist	BeOne Medicines Ltd. (ONC)
fpa150	FIVE PRIME THERAPEUTICS, INC. (FPRX)
GDC-9545	Myovant Sciences Ltd. (MYOV)
IDE574	IDEAYA Biosciences, Inc. (IDYA)
iev407	NOVARTIS AG (NVSEF)
iev407	Novartis AG (NVS)
imgc936	ImmunoGen, Inc. (IMGN)
Imlunestrant	ELI LILLY & Co (LLY)
Inavolisib	Merus N.V. (MRUS)
Iopamidol	BridgeBio Pharma, Inc. (BBIO)
ivac_w_bre1_uid	BioNTech SE (BNTX)
leucovorin	Enliven Therapeutics, Inc. (ELVN)
Lm-GUCY2C vaccine	UNITED THERAPEUTICS Corp (UTHR)
LOXO-783	ELI LILLY & Co (LLY)
ly3484356	ELI LILLY & Co (LLY)
LY4257496	ELI LILLY & Co (LLY)
Mammaglobin-A DNA Vaccine	UNITED THERAPEUTICS Corp (UTHR)
men2312	STEMLINE THERAPEUTICS INC (STML)
Mesna	Structure Therapeutics Inc. (GPCR)
Mesothelin-targeted T cells	UNITED THERAPEUTICS Corp (UTHR)
NUV-1176	Nuvation Bio Inc. (NUVB)
Omnipaque 350	BridgeBio Pharma, Inc. (BBIO)
oncr-177	Oncorus, Inc. (ONCR)
ono-4578	CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
OP-3136	Olema Pharmaceuticals, Inc. (OLMA)
Oral DNA Vaccine	ENANTA PHARMACEUTICALS INC (ENTA)
p-muc1c-allo1	Poseida Therapeutics, Inc. (PSTX)
p-muc1c-allo1 car-t cells	Poseida Therapeutics, Inc. (PSTX)
Paracetamol	PROTHENA CORP PUBLIC LTD CO (PRTA)
Paracetamol	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
pepinemab	GH Research PLC (GHRS)
Personalized cancer immunotherapeutic	Filana Therapeutics Inc. (FLNA)
PH FDC SC	ENANTA PHARMACEUTICALS INC (ENTA)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
Poly Polymerase Inhibitor	ENANTA PHARMACEUTICALS INC (ENTA)
poly-ICLC	Filana Therapeutics Inc. (FLNA)
pritumumab	Nascent Biotech Inc. (NBIO)
Pumitamig	Merus N.V. (MRUS)
rimiducid	Poseida Therapeutics, Inc. (PSTX)
Sacituzumab Govitecan	Merus N.V. (MRUS)
sar439859 microtracer	Sanofi (SNY)
Selicrelumab	Merus N.V. (MRUS)
SGN-LIV1A	Merus N.V. (MRUS)
tdxd	ASTRAZENECA PLC (AZN)
tos-358	MEDICINES CO /DE (MDCO)
Tucatinib	Merck & Co., Inc. (MRK)
xmt-1660	Mersana Therapeutics, Inc. (MRSN)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)
Zoledronic acid	Aclaris Therapeutics, Inc. (ACRS)
Zumsemetinib	Aclaris Therapeutics, Inc. (ACRS)

Preclinical(26)

Drug	Company
aktx-101	Akari Therapeutics Plc (AKTX)
Alpha-201 Macro1	Candel Therapeutics, Inc. (CADL)
amooranin-me	ENZYMEBIOSYSTEMS (ENZB)
apvo455	Aptevo Therapeutics Inc. (APVO)
ATNM-400	Actinium Pharmaceuticals, Inc. (ATNM)
breastcheck	Odyssey Health, Inc. (ODYY)
BRST-33	CNBX Pharmaceuticals Inc. (CNBX)
CBO421	Cidara Therapeutics, Inc. (CDTX)
cryptophycin-adc	Lantern Pharma Inc. (LTRN)
cx-908	CytomX Therapeutics, Inc. (CTMX)
EO-1022	Elevation Oncology, Inc. (ELEV)
gtb-5550	GT Biopharma, Inc. (GTBP)
id-based diagnostic/prognostic products	ANGIOGENEX, INC. (AGGX)
imt-001	IMMAGE BIOTHERAPEUTICS CORP. (IMMG)
io112	IO Biotech, Inc. (IOBT)
kat6a degrader	Prelude Therapeutics Inc (PRLD)
kros 401	Kairos Pharma, LTD. (KAPA)
lnth-2403	Lantheus Holdings, Inc. (LNTH)
mapkapk2 inhibitor	METASTAT, INC. (MTST)
neo-sv-01	Neon Therapeutics, Inc. (NTGN)
pan-mutant pi3kα inhibitor	OnKure Therapeutics, Inc. (OKUR)
SNAP-CAR Platform	Coeptis Therapeutics Holdings Inc. (COEP)
STAT6 inhibitor program	ENANTA PHARMACEUTICALS INC (ENTA)
StemPrintER	Accustem Sciences Inc. (ACUT)
ttx-sipdl1	Transcode Therapeutics, Inc. (RNAZ)
xp-105	XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (BCACU)

Unknown(6)

Drug	Company
EndoPredict	MYRIAD GENETICS INC (MYGN)
et mono ± lhrh	Novartis AG (NVS)
et mono ± lhrh	NOVARTIS AG (NVSEF)
HLX11	Organon & Co. (OGN)
Milkyway	AIBOTICS, INC. (AIBT)
MyRisk	MYRIAD GENETICS INC (MYGN)

Early Phase 1(3)

Drug	Company
C-peptide	ENANTA PHARMACEUTICALS INC (ENTA)
Zymosan	UNITED THERAPEUTICS Corp (UTHR)
α-lactalbumin vaccine	UNITED THERAPEUTICS Corp (UTHR)

N/A(15)

Drug	Company
Anti-Hypertensive medications	UNITED THERAPEUTICS Corp (UTHR)
Conventional Chemotherapy	Valneva SE (VALN)
Ketamine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Ketamine	Cidara Therapeutics, Inc. (CDTX)
Ketamine	Structure Therapeutics Inc. (GPCR)
Ketamine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Ketamine	Filana Therapeutics Inc. (FLNA)
Nalbuphine	Filana Therapeutics Inc. (FLNA)
Nalbuphine	Structure Therapeutics Inc. (GPCR)
Nalbuphine	Cidara Therapeutics, Inc. (CDTX)
Nalbuphine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Nalbuphine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Paracetamol	Structure Therapeutics Inc. (GPCR)
Paracetamol	Cidara Therapeutics, Inc. (CDTX)
treatment based on the results of drug sensitivity analysis	Merus N.V. (MRUS)

Phase 1/Phase 2(23)

Drug	Company
[177lu]lu-neob	Novartis AG (NVS)
[68ga]ga-neob	Novartis AG (NVS)
avzo-021	AVENUE THERAPEUTICS, INC. (ATXI)
avzo-023	AVENUE THERAPEUTICS, INC. (ATXI)
bnt323	BioNTech SE (BNTX)
byl719	Novartis AG (NVS)
Chemotherapy	Merus N.V. (MRUS)
dcellvax	Regen BioPharma Inc (RGBPP)
eci830	Novartis AG (NVS)
eci830	NOVARTIS AG (NVSEF)
erw316	Novartis AG (NVS)
gvv858	Novartis AG (NVS)
GVV858	Novartis AG (NVS)
l-nmma	Galera Therapeutics, Inc. (GRTX)
lee011	Novartis AG (NVS)
lp-184	Lantern Pharma Inc. (LTRN)
pf-07220060	PFIZER INC (PFE)
Pumitamig	BioNTech SE (BNTX)
ryz101	RayzeBio, Inc. (RYZB)
STX-478	ELI LILLY & Co (LLY)
talimogene laherparepvec	GH Research PLC (GHRS)
tislelizumab	HUTCHMED (China) Ltd (HMDCF)
zn-telomir	Telomir Pharmaceuticals, Inc. (TELO)

Phase 2/Phase 3(2)

Drug	Company
eik1003	Eikon Therapeutics Inc. (EIKN)
iza-bren	BRISTOL MYERS SQUIBB CO (BMY)

Phase 4(23)

Drug	Company
[177lu]lu-neob	Novartis AG (NVS)
Ad5.F35-hGUCY2C-PADRE vaccine	UNITED THERAPEUTICS Corp (UTHR)
adavosertib 150 mg bd + olaparib 200 mg bd	ASTRAZENECA PLC (AZN)
Administration of ceralasertib and olaparib	ASTRAZENECA PLC (AZN)
Administration of ceralasertib in combination with olaparib	ASTRAZENECA PLC (AZN)
Alpelisib	Novartis AG (NVS)
Ansastrozole	Novartis AG (NVS)
AZD8205 in combination with AZD9574	ASTRAZENECA PLC (AZN)
Bortezomib	Merus N.V. (MRUS)
ceralasertib 160 mg od + olaparib continuous 300 mg bd	ASTRAZENECA PLC (AZN)
DC1 Vaccine	UNITED THERAPEUTICS Corp (UTHR)
Dexmedetomidine Injection [Precedex]	COGNITION THERAPEUTICS INC (CGTX)
Enzalutamide	KYNTRA BIO INC. (KYNB)
Investigator's Choice of Chemotherapy	Filana Therapeutics Inc. (FLNA)
Leuprolide	Myovant Sciences Ltd. (MYOV)
Leuprolide Acetate	Myovant Sciences Ltd. (MYOV)
Neoadjuvant olaparib	ASTRAZENECA PLC (AZN)
Olaparib	UNITED THERAPEUTICS Corp (UTHR)
Olaparib	ASTRAZENECA PLC (AZN)
olaparib continuous 300 mg bd	ASTRAZENECA PLC (AZN)
Paracetamol	Filana Therapeutics Inc. (FLNA)
rF1V vaccine	UNITED THERAPEUTICS Corp (UTHR)
Taxane Chemotherapy	Merus N.V. (MRUS)

Compare drugs

ABRAXANE vs afinitor ABRAXANE vs Aware Breast Self-Exam product ABRAXANE vs Aybintio (SB8)

Frequently asked questions

How many drugs are in development for Breast?

BioSniper tracks 510 drugs in development for Breast across 130 companies.

How many clinical trials target Breast?

There are 3 clinical trials targeting Breast tracked by BioSniper.

Deep-dive into Breast

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis